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ABSTRACT: We present an in-depth investigation of the membrane
interactions of peptidoglycan (PGN)-based immune adjuvants designed for
lipid-based delivery systems using NMR spectroscopy. The derivatives contain a
cargo peptidoglycan (PGN) dipeptide fragment and an adamantyl group, which
serves as an anchor to the lipid bilayer. Furthermore, derivatives with a mannose
group that can actively target cell surface receptors on immune cells are also
studied. We showed that the targeting mannose group and the cargo PGN
fragment are both available on the lipid bilayer surface, thereby enabling
interactions with cognate receptors. We found that the nonmannosylated
compounds are incorporated stronger into the lipid assemblies than the
mannosylated ones, but the latter compounds penetrate deeper in the bilayer.
This might be explained by stronger electrostatic interactions available for
zwitterionic nonmannosylated derivatives as opposed to the compounds in which
the charged N-terminus is capped by mannose groups. The higher incorporation efficiency of the nonmannosylated compounds
correlated with a larger relative enhancement in immune stimulation activities upon lipid incorporation compared to that of the
derivatives with the mannose group. The chirality of the adamantyl group also influenced the incorporation efficiency, which in turn
correlated with membrane-associated conformations that affect possible intermolecular interactions with lipid molecules. These
findings will help in improving the development of PGN-based immune adjuvants suitable for delivery in lipid nanoparticles.
■ INTRODUCTION
Development of safe and effective adjuvants in vaccine
research is still a challenge1 as many effective immune
modulatory compounds have significant adverse effects, while
commonly used safe adjuvants, such as alum,2 are not very
potent. Stimulation of the immune response and modulation of
the appropriate type of immunity can be achieved by activation
of the innate immune system via activation of pattern
recognition receptors (PRRs) expressed on immune cells and
other cells. Targeting different PRRs by microbial danger
signals, so-called pathogen-associated molecular patterns
(PAMPs), triggers signaling cascades, leading to specific
proinflammatory responses. Immune adjuvants with various
characteristics thus can be obtained using fragments or
analogues of PAMPs.3
Bacterial cell wall peptidoglycan (PGN) is one of the most
important microbial signatures recognized by innate immune
receptors. PGN is recognized4 by intracellular nucleotide
oligomerization domain (NOD)-like receptors NOD1 and
NOD2 and secreted peptidoglycan recognition proteins,
among others. It has been shown that polymeric PGN can
stimulate immune defenses even without the presence of an
infection; therefore, it can act as a very potent adjuvant.5
However, it also has too many side effects to be used in
vaccines.6 Fragments and substances7 derived from PGN also
exhibit weaker adjuvant activities with diminished adverse
effects. One of the most widely used PGN fragments is
muramyl dipeptide8 (MDP) containing the N-acetylmuramyl-
L-alanyl-D-isoglutamine (L-Ala-D-iGln) motif of PGN, which is
the minimal essential unit of PGN. MDP is recognized by
NOD2,9 a cytoplasmic receptor of the innate immune system,
and has a weak immune modulatory effect8 as it is rapidly
excreted into the urine, and its administration is associated
with various adverse side effects.
To improve the adjuvant properties of PGN fragments, an
appropriate drug delivery system is needed, which can improve
metabolic stability and bioavailability, enable reduction of
therapeutic doses, and thereby reduce adverse effects. The use
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of lipid nanoparticles as carriers is well-established10 and has
found widespread applications in vaccination as many carriers
are able to stimulate the immune system and induce both
cellular and humoral immune responses.11 Similarly, many
lipophilic derivatives of MDP were developed to increase
loading in lipid carriers,11,12 which increased adjuvant activities
and reduced side effects.13
The PGN derivatives14 we investigate in this study are
designed to be suitable for encapsulation into liposomes. These
derivatives contain only a minimal PGN fragment, L-Ala-D-iGln
payload, and an adamantyl group to increase hydrophobicity
and to facilitate anchoring of the PGN fragment cargo to the
membrane. Due to the chirality of the adamantyl group, two
diastereoisomers were obtained (Scheme 1a,b), which were
both shown to be stable, nonpyrogenic, water-soluble, and
nontoxic and displayed an adjuvant effect in vivo in mice
models.15,16
Adamantane-based drugs are used as antivirals17,18 as well as
in the treatment of Parkinson’s19,20 and Alzheimer’s21,22
diseases. They often act as channel blockers,23−25 but their
therapeutic effect was also suggested to be related to
nonspecific interactions with membranes.26,27 Indeed, the
hydrophobicity and unique geometry of adamantane are
thought to increase the membrane permeability and adsorption
of drugs and as a result significantly modify the pharmaco-
logical profile of drug molecules. Amantadine (1-amino-
adamantane) is one of the oldest and most well-known
adamantane-containing drugs, and its membrane interaction is
thought to play a crucial role in its activity.28−30
We also investigated versions of the adamantylated PGN
compounds conjugated to mannose moieties (Scheme 1c,d).
Glycosylation with carbohydrates that specifically bind to
endogenous lectin receptors on cell surfaces achieves active
targeting, which is an important aspect of any drug delivery
system as it is more controllable and efficient than passive
targeting. Effectiveness of targeting using mannose was shown
for mannosylated liposomes, which were found to enhance the
uptake and activation of dendritic cells and to increase T cell
proliferation.31 In this fashion, antigen-presenting cells (APCs)
are targeted, such as macrophages and dendritic cells that
express C-type lectins (CLRs), which can recognize the
mannose-targeting group. CLR recognition may result in
improved internalization and presentation of antigens by
antigen-presenting cells32 and may also modulate the immune
Scheme 1. Chemical Structure of the Investigated PGN Derivativesa
a
D-Ad1Tp: D-(adamant-1-yl)-Gly-L-Ala-D-isoGln, L-Ad1Tp: L-(adamant-1-yl)-Gly-L-Ala-D-isoGln, Man-D-Ad1Tp: (2R)-N-[3-(α-D-mannopyranosy-
loxy)-2-methylpropanoyl]-D-(adamant-1-yl)-Gly-L-Ala-D-isoGln, and Man-L-Ad1Tp: (2R)-N-[3-(α-D-Mannopyranosyloxy)-2-methylpropanoyl]-L-
(adamant-1-yl)-Gly-L-Ala-D-isoGln. The “Ad1” notation indicates an adamant-1-yl attachment, and the “Tp” notation stands for a tripeptide. Ada
stands for adamantylated glycine, D-iGln for D-isoglutamine, and Lnk for the linker residue including the −CH2−CH(Me)− fragment.
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response via signaling pathways.33 The former could help in
increasing the uptake of the mannosylated compounds and
thus achieve active targeting, while the latter might lead to the
modification of the host defense response triggered by the
PGN fragment via PRR crosstalk. The adjuvant activity of the
mannosylation in the adamantylated compounds was indeed
found to be amplified in vivo,14,16 which might be related to
the successful targeting of immune cells.
The PGN derivatives exhibited adjuvant activities in vivo in
experiments performed in mice models using ovalbumin
(OVA) as an antigen.14,15 Differences regarding the config-
uration on the stereogenic center of adamantyl glycine were
observed as D-Ad1Tp showed higher stimulation of anti-OVA
immunoglobulin G (IgG) antibody production in comparison
to L-Ad1Tp.
15 The best adjuvant activity was observed for the
mannosylated derivate Man-D-Ad1Tp.
16 Adjuvant effects of the
adamantylated PGN derivatives were also assessed in an in
vitro assay34 monitoring cytokine and chemokine production
in immortalized mouse bone marrow-derived macrophages.
We found that while the PGN compounds do not stimulate
macrophages alone, L-Ad1Tp and, in particular, Man-L-Ad1Tp
were able to enhance the immune responses induced by
lipopolysaccharide (LPS) on macrophages. Moreover, the co-
stimulation activity on macrophages was further increased by
the incorporation of the compounds into phosphatidylcholine
liposomes.
To develop improved adjuvant delivery systems for
vaccination, understanding of the molecular details governing
the encapsulation of adjuvants into lipid bilayers and their
interactions with the targeted receptors is mandatory. NMR
spectroscopy is a powerful technique for investigating the
molecular details of membrane interactions of lipid-embedded
molecules such as detection of binding,35 membrane-
associated structures of solutes,36 their position and orientation
in the membrane,30,37 and determination of entrapment
efficiency.38 The sign dependence35 of the nuclear Overhauser
effect (NOE) on the size of the molecule associated with the
membrane can reveal the presence of a weak interaction,36 and
the structure of the membrane-bound conformation can be
determined using intramolecular transferred NOEs. Diffusion
ordered spectroscopy (DOSY)39 provides means to measure
the lipid entrapment efficiency of molecules38 by determining
the ratio of the free and bound solute in the case of fast
exchange between the solutes and the bilayer. Furthermore,
saturation transfer difference (STD)40 spectroscopy is used to
probe the depth and orientation of the molecule within the
lipid bilayer30 via an epitope mapping procedure.41,42 Solvent-
accessible fragments of molecules immersed in membranes can
be monitored37 using water-soluble paramagnetic probes by
inducing paramagnetic relaxation enhancement (PRE),43
which can be detected by the measurement of transverse
relaxation times44 (T2).
To promote the therapeutic impact of the antigen and
adjuvant payload, vaccine formulations are required45 to retain
their cargo and to improve their exposure to receptors. In this
report, we investigated all four PGN fragment-containing
derivatives shown in Scheme 1 using the above NMR
spectroscopic methods to reveal the molecular details of
their interaction with lipid molecules such as their lipid
encapsulation efficiency, their membrane-associated conforma-
tions, and the location and orientation of the derivatives within
the bilayer. These investigations allow assessing whether
sufficient membrane incorporation can be achieved for their
safe delivery in a lipid-based formulation and also to reveal the
availability of the targeting group and the PGN cargo fragment
toward interaction with their corresponding receptors for
active targeting.
Since NMR investigation of large liposomes is not
straightforward due to their size and heterogeneity, we used
isotropic bicelles46,47 as model bilayer systems. Here, a short-
chain phospholipid, used as a detergent, is mixed with long-
chain phospholipids, thereby forming disklike bilayers,48−50
with the rims covered by the detergent-like short-chained
phospholipid molecules. Bicelles are considered as good
models of lipid assemblies with bilayer structures.51−53
Specifically, phosphatidylcholine lipids with dimyristoyl and
dihexanoyl chains were used as model lipids (1,2-dimyristoyl-
sn-glycero-3-phosphocholine (DMPC))54 and detergents (1,2-
dihexanoyl-sn-glycero-3-phosphocholine (DHPC)), respec-
tively. Both DMPC and DHPC carry positively charged
choline groups and negatively charged phosphate groups in the
head region, which is then bridged by polar glycerol moieties
to the fatty acid tails. For the purpose of the NMR
characterization, we utilized a molar ratio of 0.5 between the
detergent and bilayer-forming lipids to generate isotropically
tumbling bicelles.
■ EXPERIMENTAL AND COMPUTATIONAL
METHODS
Materials. Protonated 1,2-dimyristoyl-sn-glycero-3-phos-
phocholine (DMPC) and 1,2-dihexanoyl-sn-glycero-3-phos-
phocholine (DHPC) with more than 99% purity were
purchased from Avanti Polar Lipids, Inc. in a powder form.
Deuterium oxide (D2O) with a purity of more than 99.9 atom
% D was purchased from EurisoTop (France). N-Acetyl-
glucosamine (NAG) was purchased from Sigma-Aldrich. PGN
derivatives were synthesized as previously described.14,15
NMR Spectroscopy. The NMR samples contained ca. 20
mg of the PGN derivatives dissolved in 500 μL of water
containing 10% D2O. Later, an aliquot of the aqueous sample
was used for preparing a lipid bicelle sample with ca. 8 mM
PGN compound concentration in 100 mM K phosphate buffer
at pH 7.2. The concentrations of 100 mM DMPC and 200
mM DHPC were used for making the lipid bicelle solution
with a molar ratio of q = 0.5 according to described
procedures.47 NMR experiments were performed at 298.3
and 310.2 K on a Bruker Avance II NMR spectrometer
operating at 700.13 MHz equipped with a 5 mm TXI-Z probe.
The 1H resonances were assigned using standard homonuclear
and heteronuclear correlation experiments.
Determination of Diffusion Coefficients. Diffusion
coefficients were measured by pulsed-gradient stimulated-
echo (PGSTE) NMR with a stimulated spin echo sequence
with bipolar gradients, one spoil gradient, and a 3-9-19 water
suppression scheme.55 The maximum gradient strength of the
probe was 57.7 G/cm. The diffusion delay was set to 200 ms,
while the gradient length was 2 ms and varied in intensity
between 2 and 95% of the maximum gradient strength in 64
steps. Spectra were recorded with 256 scans. Two-dimensional
(2D) DOSY plots were generated using TOPSPIN 3.1.
Nonoverlapping resonances and showing pure monoexponen-
tial decay were used to extract the diffusion coefficient of the
associated species by fitting to the appropriate Stejskal−
Tanner equation56 using an in-house fitting procedure
implemented in MATLAB.
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Structure Calculation of the Membrane-Associated
State. Distance restraints were extracted from a 2D NOE
spectroscopy (NOESY) spectrum recorded with 100 ms
mixing time at 700.13 MHz at room temperature. All
transferred NOE cross-peaks were manually assigned and
integrated using the CCPNMR software.57 Signals arising from
γ and ε positions of methylene groups in the adamantyl moiety
could not be unambiguously assigned; therefore, ambiguous
restraints were implemented. The signal intensities were
converted into distances by calibration against the average of
the integrals of all NOE intensities, corresponding to a
reference distance of 3.2 Å. For structure calculations, the
simulation engine CNS 1.358 was employed using a simulated
annealing algorithm in the torsion angle space with subsequent
refinement in explicit water.59 The CNS force field used for
peptides with explicit hydrogens was supplemented with
topologies and parameters developed for an amino acid
containing the adamantyl group in D and L configurations,
the linker residue, and D-iGln. An ensemble of structures was
generated using an acceptance test, selecting structures with no
bond length, valence angle, and NOE violations. The obtained
structures were aligned along Cα atoms using Discovery Studio
Visualizer 3.5.60 The structures were visualized in PyMOL.61
Saturation Transfer Difference Experiments. STD
spectra were recorded using a pulse sequence with interleaved
on- and off-resonance experiments.40 Saturation of the lipid
resonances was performed using a train of selective Gaussian
pulses of 49 ms duration and 75 Hz field strength each,
separated by a 1 ms delay. The on-resonance frequency used
for saturation of the lipid signals was set to 0.74 ppm for the
lipid tail (the fatty acid chain terminal methyl group of DMPC,
14-Me) and 5.22 ppm for lipid head groups (2′CH of glycerol
in DMPC/DHPC). The off-resonance irradiation was applied
at −50 ppm outside the area of NMR resonances. The overall
saturation time was 6 s, and 4096 scans were measured. For the
epitope mapping analysis,41 STD signals in the amide region
were used because the aliphatic region of the spectra was
dominated by the lipid signals. Control experiments were run
using aqueous samples of the derivatives and resulted in no
signals, thus confirming that no glycopeptide resonances were
irradiated. The resulting intensities were normalized to
reference spectrum intensities with irradiation at −50 ppm,
and STD amplification factors were obtained. Furthermore, the
STD amplification factors were corrected for differences in T1
relaxation times of the individual ligand protons.62,63 We
measured STD signal buildups with saturation times of 1, 4,
and 8 s as shown in Figure S5. For the larger mannosylated
compounds, the STD amplification factors started to decline at
8 s of saturation time. However, the STD signal patterns are
similar for all three saturation times. For this reason, only the
STD effects observed with 4 s saturation time are quantified
and discussed for epitope mapping.
Determination of 1H T1 Relaxation Times.
1H T1
relaxation times were determined in inversion recovery
experiments. The water signals were suppressed using
excitation sculpting.64 The interscan delay was set to 6 s.
The delay during the inversion recovery measurements was
varied between 50 ms and 5 s, randomly sampled over 16
experiments. The T1 relaxation time constants were fitted to
the obtained data points with the T1/T2 analysis function
implemented in TopSpin 3.1.
Paramagnetic Relaxation Enhancement (PRE) Experi-
ments. A manganese(II) ion was used as a water-soluble
paramagnetic relaxation agent in the form of a MnCl2 solution,
which was added to the samples containing the 8 mM PGN
derivative and 100 mM DMPC and 200 mM DHPC at 0.5, 1,
and 2 mM concentrations. The effect of the paramagnetic ions
was monitored by determination or estimation of T2 relaxation
times. At low paramagnetic ion concentrations, the 1H T2
relaxation times were determined in a Carr−Purcell−
Meiboom−Gill (CPMG) experiment using the pulse sequence,
removing J modulation.65 The water signal was suppressed
using excitation sculpting.64 The interscan delay was set to 6 s.
The delay in the spin echo was 1.5 ms, and the total echo time
was varied between 6 and 1248 ms, randomly sampled over 16
experiments. The T2 relaxation time constants were fitted to
the obtained data points with the T1/T2 analysis function
implemented in TopSpin 3.1. For estimation of T2 relaxation
times at higher paramagnetic ion concentrations, line widths of
resonances in the one-dimensional (1D) 1H NMR experiment
were determined using the deconvolution routine in TopSpin
3.1. The transverse paramagnetic relaxation enhancement
(PRE) rate was defined as a slope of the fitted linear function
for the first two points of the titration, for which the
attenuation was the largest.37
C-Type Lectin Binding. We used plant lectin, concanava-
lin A (Con A), to assess C-type lectin binding capability of the
PGN drug delivery complexes. Since calcium ions are required
for concanavalin A binding, samples of the PGN derivatives
were prepared with 8 mM glycopeptide, 100 mM DMPC, and
200 mM DHPC concentrations in 100 mM NH4OAc buffer
and 2 mM CaCl2 as a reference without and with the addition
of concanavalin A (1 mM). These NMR experiments were
carried out in a 1 mm capillary NMR probe measured in a 1
mm triple-inverse room-temperature probe with gradients
(Bruker TXI-Z).
■ RESULTS AND DISCUSSION
To gain insight into the interactions between the PGN
derivatives and the lipid bilayer, we investigated their DMPC−
DHPC bicelle model formulations. To focus on the
interactions between the peptide and the lipid molecules, the
concentrations of the long-chain lipid DMPC (100 mM) were
applied in ca. 10-fold excess compared to those of the
derivatives (ca. 8 mM). The 1H NMR spectra of the
formulations are dominated by the lipid signals in the aliphatic
region, and only the amide group signals of the PGN
derivatives are present in the low-field 1H NMR region. The
signals of the fatty acid chains of DMPC and DHPC are
somewhat separated, with the terminal methyl groups fully
resolved, but the resonances of the polar head groups are in a
complete overlap. Despite using nondeuterated lipids, a
number of peptide resonances were completely free from the
overlap with the larger lipid signals in the aliphatic region as
illustrated in the 1H NMR spectrum of D-Ad1Tp in Figure S1.
These nonoverlapping resonances in the aliphatic region and
the amide signals were assigned, and their T1 or T2 relaxation
times needed for the evaluation of STD and PRE data were
determined. It was, however, not possible to detect STD effects
for resonances in the aliphatic region because STDs have only
a fraction of the original signal intensity and drown in the
presence of the larger lipid signals. Also, at high paramagnetic
ion concentrations, T2 relaxation times could only be estimated
from line widths in the aliphatic region.
Detection of the Interaction by Monitoring the Sign
of the Transient NOE. Since the 1H NMR spectrum did not
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reveal significant line broadening of the peptide signals (Figure
S2), we recorded 2D NOESY spectra to determine the sign of
the NOEs, which is dependent on the global motional
characteristics of the assembly and thus the size of the
molecular species. Positive NOEs were detected in aqueous
solutions, and large, negative NOEs were observed in the
presence of the bicelles as depicted in Figure S3. Observation
of the NOE sign change from positive to negative indicated
interaction of the PGN derivatives with the lipid bilayer. As a
control, we used N-acetyl-D-glucosamine (NAG), which is an
uncharged polar molecule and therefore expected to have little
or no interaction with the fatty acid side chains of the lipid
molecules. For NAG, weakly positive NOEs were observed
both in the aqueous solution and in the presence of bicelles as
shown in Figure S2e.
Only a single set of resonances was observed for the PGN
derivatives in the presence of bicelles, which indicates that the
molecules are in fast exchange between the lipid bilayer and
the aqueous solution on the chemical shift time scale. The
detected NOEs under fast exchange conditions are transferred
NOEs36 carrying information on the bound conformation. No
intermolecular NOE contacts between the PGN derivatives
and the bilayer were detected in the NOESY or the rotating
frame NOESY (ROESY) experiment. This is, however, not
unusual for molecules with weak to intermediate affinity to
membranes.30
Thus, the PGN derivatives are partially bound to the bilayer
and partially solvated in the aqueous phase in a dynamic
equilibrium. In a liposome-based delivery system to be used in
a vaccination context, the PGN derivatives would be likely in
part intercalated into the lipid bilayer and in part entrapped in
the inner aqueous compartment.
Determination of the In Situ Encapsulation Efficiency
by the Measurement of Translational Diffusion. Changes
in translational diffusion coefficients in the presence of bicelles
compared to those in the aqueous solution of the PGN
derivatives provided another piece of evidence of the
interaction. DOSY plots of the PGN derivatives in bicelles
show a significant drop in the translational diffusion coefficient
compared to that in the aqueous solution (Figure 1). The
diffusion coefficient of NAG in an aqueous buffer solution is
very similar to its value in the presence of bicelles (Figure 1e),
except for a small difference probably due to different sample
viscosity.
A single set of signals was observed in the diffusion
dimension for each species; thus, the derivatives are in fast
exchange not only on the chemical shift scale but also on the
diffusion time scale. This provided an opportunity to use the
diffusion coefficients to quantify the lipid encapsulation
efficiency.
The decays of the peptide signals generated in the diffusion
experiment and used in a numerical fitting are monoexponen-
tial when plotted against the square of the gradient strength
(Figure S4), which indicates that the exchange regime on the
diffusion time scale is fast compared to the inverse of the
diffusion delay (200 ms). Assuming a two-site exchange of the
Figure 1. DOSY plot of compounds at 25 °C: (a) D-Ad1Tp, (b) L-Ad1Tp, (c) Man-D-Ad1Tp, (d) Man-L-Ad1Tp, and (e) NAG in the presence (red)
and absence (black) of bicelles.
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derivatives between the bicelle-bound and free solvated forms,
we can use the diffusion constants of the different molecular
species to estimate the fraction of peptides bound to the lipid
bilayer and to calculate the encapsulation efficiency.30,66,67
Under fast exchange conditions, the observed diffusion
coefficient is a population average of the diffusion coefficients
of the molecules freely diffusing in the aqueous solution and
that of the molecules bound to the bicelle
= + −D p D p D(1 )obs lipid bicelle lipid free
where Dobs is the observed diffusion coefficient of the
compound in the presence of bicelles, Dbicelle is the diffusion
coefficient of the bicelle as measured on the DMPC terminal
methyl signal, Dfree is the diffusion coefficient of the compound
in the aqueous phase, and plipid is the fraction of compounds
encapsulated in lipid bicelles.
Furthermore, the measured diffusion coefficients of the PGN
derivatives are corrected for the obstruction effect arising from
the reduced volume available for the assemblies to diffuse, thus
providing the diffusion coefficient at infinite dilution
= − ΦD D k(1 2 )obs measured
where Dobs is the diffusion coefficient at infinite dilution;
Dmeasured is the measured diffusion coefficient; k is a shape-
dependent factor assuming the near-spherical shape of the
bicelles;68 and Φ is the volume fraction, which was
approximated by the weight fraction of phospholipids
excluding the monomer DHPC.30,48 Finally, to account for
different viscosities in the aqueous and the bicelle solutions, a
correction factor was used based on the ratio of the diffusion
coefficients of water in the two solutions (234 μm2/s in water
and 253 μm2/s in bicelles with q = 0.566).
Thus, the fraction of the compounds incorporated in the
lipid bicelles (plipid) and their partition coefficient (Kp) can be
determined as follows
= − −p D D D D( )/( )lipid free obs free lipids
= −K p p/(1 )p lipid lipid
The diffusion properties of the bicelle can be estimated by the
diffusion of DMPC, which is only present in the bicelles and
does not dissolve in the aqueous solution as opposed to
DHPC.66 The diffusion constant of the bicelles without added
compounds was 53.4 ± 0.4 μm2/s at room temperature and
59.2 ± 0.7 μm2/s at 37 °C. These values agree well with 5.2 ×
10−11 and 6.4 × 10−11 m2/s found in the literature.69,70 The
hydrodynamic radii of bicelles with q = 0.5 DMPC/DHPC
ratio has been reported in the range of 3−4.5 nm49 at
temperatures between 18 and 40 °C.
Numerical diffusion constants determined by fitting and
encapsulation efficiencies at 25 and 37 °C are shown in Tables
1 and 2, respectively. The bicelle diffusion constants did not
change significantly when NAG was added. In the presence of
the PGN compounds, the bicelle diffusion constants decreased
for the L diastereoisomers, indicating that the bicelles became
larger at room temperature and did not significantly change for
the diastereoisomers at room temperature. At 37 °C, the
bicelle diffusion constants increased, pointing to the presence
of smaller bicelles with a larger increase for Man-D-Ad1Tp. The
increase of bicelle size upon the insertion of peptides has been
frequently reported. At 25 °C, the DMPC diffusion increases
to 3.5 × 10−11 m2/s with C-peptide71 and to 2.4 × 10−11 m2/s
with viscosinamide.72 At 37 °C, it increases to 2.5 × 10−11 m2/
s in the presence of penetratin73 to 2.8 × 10−11 m2/s with
motilin66 and to 5.0 × 10−11 m2/s with KALP21.69 These
peptides are, however, much larger than the PGN compounds
and are known to penetrate the membrane. The bicelle
diffusion constant was found to be 6.21 × 10−11 m2/s in the
presence of amantadine30 at 25 °C, however, with q = 0.3
DMPC/DHPC bicelles.
The lipid incorporation values are between 19 and 49% at
room temperature and 42 and 56% at 37 °C. In comparison,
the incorporation efficiency of the peptidoglycan monomer74
fragment isolated from Gram-negative bacteria embedded into
lipid bilayers is 16−23% as determined by an high-perform-
ance liquid chromatography (HPLC)-based method.75 Thus, a
significant increase in the membrane incorporation efficiency
could be achieved by the inclusion of the lipophilic
adamantane group compared to the unsubstituted peptidogly-
can monomer immune modulator, which improves ligand
density on the surface of lipid nanoparticle formulations. Lipid
entrapments of 22 and 35% were determined for isomers of the
adamantyl compounds with adamantyl-2-yl attachment, D-
Ad2Tp and L-Ad2Tp,
75 respectively (depending on the method
of preparation, 23 and 30% were also measured). The lipid-to-
peptide ratio in these preparations was closer to 1:1 rather than
10:1 in the NMR investigation, which could explain lower
incorporation values. Membrane partitioning (Kp) of spin-
labeled amantadine was found to be 11.2 at 45 °C in DMPC
vesicles using electron paramagnetic resonance (EPR)29 and
27.6 in DMPC and 37.8 in 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) lipids using NMR,30 which are much
larger than the partition coefficients determined here.
Amantadine is, however, much smaller in size than the
derivatives studied here and has only a single charged group.
By comparing the values, two observations may become
relevant for the design of these molecules. Previously, we have
shown34 that the peptide co-stimulation activity to LPS on
Table 1. Diffusion Coefficients Determined in the Aqueous
and the Lipid Phase, the Derived Lipid-Bound Fraction, and











D-Ad1Tp 55.0 ± 0.2 383 ± 1.7 215 ± 7.1 0.32 0.47
L-Ad1Tp 43.5 ± 0.7 376 ± 1.7 162 ± 0.1 0.49 0.96
Man-D-
Ad1Tp
58.1 ± 0.2 268 ± 4.3 151 ± 4.8 0.19 0.23
Man-L-
Ad1Tp
41.8 ± 0.1 283 ± 7.7 185 ± 3.5 0.24 0.32
NAG 54.6 ± 0.2 536 ± 17.3 388 ± 2.3 0.01 0.01
Table 2. Diffusion Coefficients Determined in the Aqueous
and the Lipid Phase, the Derived Lipid-Bound Fraction, and











D-Ad1Tp 82.1 ± 0.3 622 ± 10.0 304 ± 8.3 0.51 1.05
L-Ad1Tp 86.9 ± 0.6 537 ± 15.8 252 ± 11.2 0.56 1.26
Man-D-
Ad1Tp
107.5 ± 1.8 480 ± 10.6 288 ± 15.2 0.43 0.75
Man-L-
Ad1Tp
86.6 ± 0.2 495 ± 12.1 262 ± 15.9 0.42 0.72
NAG 55.7 ± 0.2 549 ± 9.8 469 ± 20.0 0.02 0.02
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macrophages was further increased by the incorporation of the
compounds into phosphatidylcholine lipid bilayers. Only L-
Ad1Tp and Man-L-Ad1Tp were investigated in the in vitro
assay for this effect. Albeit that the adjuvant effect of Man-L-
Ad1Tp both in the aqueous solution and in liposomes was
better, the relative increase of the adjuvant effect upon the
incorporation of L-Ad1Tp compared to that in the aqueous
solution was more significant. Thus, L-Ad1Tp profited more
from the lipid delivery system than Man-L-Ad1Tp and this may
be related to the higher lipid incorporation efficiency of the
nonmannosylated compound compared to that of the
derivative with the mannose group.
We may also see a slight influence of the chirality of the
adamantyl group attachment. Immune co-stimulation activities
to LPS in vitro were also shown to be dependent on the
chirality of the adamantyl group attachment,34 but this is likely
related to molecular details of the receptor interaction. Of the
nonmannosylated diastereoisomer pair, D-Ad1Tp appears to
interact weaker with the lipid bilayer than L-Ad1Tp. This
difference is slightly more pronounced at low temperature (32
vs 49%) and present to much less degree at high temperature
(51 vs 56%). For the mannosylated derivatives, the
encapsulation between the diastereoisomers differs less at
room temperature (19 vs 24%) and is similar at 37 °C (43 vs
42%). Nevertheless, the differences might be attributable to the
experimental uncertainty of the lipid incorporation efficiencies.
Characterization of the Membrane-Associated Con-
formation with Transferred NOEs. To get insight into the
range of conformations available for the PGN derivatives in the
lipid bilayer bound state, we used transferred NOEs detected
in the presence of bicelles at room temperature (Table S1) to
calculate the structures associated with the membrane. For D-
Ad1Tp and L-Ad1Tp, 25 and 14
1H−1H distances were
extracted, respectively, while for Man-D-Ad1Tp and for Man-L-
Ad1Tp, the distances were 26 in both cases. The calculated
ensembles are shown in Figure 2.
The distance restraints derived from transferred NOEs do
not determine a single conformation but rather a range of
structures. However, certain trends can be observed. For the
nonmannosylated derivatives, the backbone was more or less
extended for the majority of L-Ad1Tp structures (Figure 2a),
while, for D-Ad1Tp, the C-terminus tends to bend back to the
N-terminus (Figure 2b). This bent conformation in D-Ad1Tp is
enforced by a series of unique restraints from the Ala-NH to
the Ada side chain (denoted in bold in Table S1). While the
structures of the nonmannosylated derivatives depicted in
Scheme 1 show neutral forms, the peptide termini are likely
zwitterionic in the aqueous solution; thus, this bent
conformation is likely driven by an intramolecular electrostatic
contact between the N-terminal amine group and the C-
terminal carboxyl group of the derivative.
In the case of the mannosylated derivatives, the transferred
NOEs define extended conformations for Man-D-Ad1Tp, while
Man-L-Ad1Tp displayed structures with a somewhat bent
backbone, with two of the conformations showing a close
contact between their termini as shown in Figure 2c,d. As
before, we note that the structures of the mannosylated
derivatives in Scheme 1 are depicted in neutral forms, while, in
the aqueous solution, ionized states are likely present with a
negative charge in the carboxyl group at the C-terminal and the
N termini of the parent compounds are capped with a neutral,
albeit polar mannose group. In the strongly bent subpopulation
of Man-L-Ad1Tp, the hydroxyl groups of the mannose and the
D-iGln carboxyl group are close enough for a hydrogen-
bonding interaction, which is absent for Man-D-Ad1Tp. For
Man-L-Ad1Tp, the restraints that are responsible for the bent
conformations primarily involve NOEs from the Ala-NH group
and the D-iGln side chain to the methyl group of the Lnk
residue (denoted in bold in Table S1).
Localization and Mapping of the Orientation within
the Bilayer via STD and PREs. While both STDs and PREs
can be analyzed to yield quantitative structural,41 thermody-
namic,76 or kinetic77 properties, we performed a simpler
qualitative evaluation, aiming at a complementary epitope
mapping of the lipid-associated and the solvent-accessible parts
of the investigated molecules.
STD Spectroscopy. We performed STD experiments to
characterize the orientation of the derivatives in the bilayer.
We observed that irradiation at the lipid tail (terminal methyl
group) and close to the lipid head (glycerol CH) groups
resulted in different STD amplification patterns. Similar effects
have been reported for amantadine in isotropic bicelles,30
whereby different STD amplification factors were observed,
depending on the lipid groups chosen to be saturated. This
effect is likely due to the fact that the spread of saturation is
not isotropic throughout the bicelle as a result of inefficient
Figure 2. Ensemble of conformations calculated using transferred
NOEs for (a) D-Ad1Tp, (b) L-Ad1Tp, (c) Man-D-Ad1Tp, and (d)
Man-L-Ad1Tp. The average structure is shown in sticks.
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spin diffusion. This phenomenon allowed determination of not
only the interacting surface of the derivatives but also the part
of the lipids where the saturation is transferred from. Hence,
the STD experiment in effect was used for mapping the
position of the molecules within the lipid bilayer similarly to
the case of amantadine.30
We performed two types of STD experiments for each
derivative as shown in Figure 3: in one experiment, the
terminal DMPC methyl signal was saturated, and in the second
experiment, the resonance of the 2′CH group of the glycerol
backbone representing the overlapping signals of DMPC and
DHPC molecules close to the lipid head was irradiated.
Identical reference experiments were performed using the
aqueous samples of the PGN derivatives, which produced no
signal (data not shown). Other lipid resonances were in an
overlap with the peptide signals that was too strong to allow
selective saturation. Only the amide group STDs of the
peptides were evaluated as the weak STD signals in the
aliphatic region were drowned by the intense signals from the
lipid molecules, preventing their detection. Special care needs
to be taken to address artifacts distorting STD effects arising
from differential relaxation times.62 The T1 relaxation times for
the corresponding amide resonances were suggested as a
correction factor for the final STD amplification factors.63
However, as the T1 relaxation times (Table S2) were very
similar to each other for a given derivative, they did not affect
significantly the STD amplification factors (Table S3).
Looking at the STD spectra, we can make one important
qualitative observation at this stage. For the nonmannosylated
tripeptides, no or very little STD signal was obtained when the
lipid tail was irradiated as compared to experiments with
irradiation close to the lipid head groups (except for a small
signal at D-iGln-NH in D-Ad1Tp). This indicates that the
nonmannosylated compounds are not in contact with the inner
parts of the bilayer. For the mannosylated compounds, STD
signals were detected in both experiments, which implies that
the mannosylated derivatives are more immersed into the
bilayer than their parent compounds.
Mapping of the STD amplification factors on the structures
as shown in Figure 4 allows the qualitative characterization of
the location and orientation of the derivatives within the lipid
bilayer. Two major conclusions can be drawn. First, the STD
signal intensity observed for the side-chain D-iGln-NH2 groups
is less intense than that of the STD for the other groups. Also,
Figure 3. STD with selective irradiation of the resonances of the lipid molecules for compounds (a) D-Ad1Tp, (b) L-Ad1Tp, (c) Man-D-Ad1Tp, and
(d) Man-L-Ad1Tp: the upper trace shows the reference
1H NMR spectrum of the amide signals, the middle trace shows selective irradiation close to
the lipid head group (DMPC/DHPC glycerol 2′-CH), and the lower trace shows selective irradiation of the lipid tail (DMPC 14-Me).
Figure 4. STD signal intensities mapped down onto the structure for
compounds (a) D-Ad1Tp, (b) L-Ad1Tp, (c) Man-D-Ad1Tp, and (d)
Man-L-Ad1Tp. The upper value indicates the STD intensity with
irradiation close to the lipid head group, while the lower value shows
the STD signal with lipid tail saturation.
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it is less intense with lipid tail irradiation than with saturation
close to the lipid head group. This indicates that the D-iGln
residue does not appear to be in close contact with the bilayer.
Second, when resonances close to the lipid head groups are
saturated, the most intense STD signal is detected at the Ala-
NH group for the nonmannosylated compounds, while the
Ada-NH moiety received most saturation for the derivatives
with mannose groups. Since the lipid resonances dominate the
aliphatic region, the mannose and adamantyl groups are in
effect invisible with STD mapping. The Ala-NH and Ada-NH
groups are the closest to the adamantyl moiety with observable
STDs to serve as reporter groups. These groups displaying the
strongest STDs thus indicate that the adamantyl group is
inserted into the bilayer deepest, at least at the level of the
glycerol moiety.
To conclude the findings of the STD studies, the
nonmannosylated parent compounds interact only with the
upper layer of the lipid bilayer, while the derivatives with
mannose groups appear to be more immersed into the
membrane. In all cases, the PGN fragment cargo is closest to
the surface according to small STDs on D-iGln-NH2 groups;
thus, the cargo PGN peptide fragment is available for
interactions with innate immune receptors in the membrane
surface, e.g., for activation of the NOD2 receptor, which
recognizes the PGN fragment9 and induces a Th1-type
immune response.
Water-Soluble Paramagnetic Probes. To investigate the
parts of the PGN derivatives that are not visible using STD due
to the dominance of strong lipid resonances in the aliphatic
region, that is, the adamantyl group and the mannosyl group,
we used PRE induced by water-soluble paramagnetic probes,
specifically by manganese(II) ions. Manganese(II) ions44
induce strong PREs due to five unpaired electrons and long
electron relaxation times, but they have an isotropic electron g-
tensor and thus do not generate pseudocontact shifts. We
monitored PRE-induced bleaching effects during titration with
paramagnetic ions for various reporter groups in the derivatives
as shown in Figure 5.
We also quantified the bleaching effect defined as the
attenuation of T2 relaxation times (Figure 6), which were
either measured in CPMG experiments or estimated from line
widths during the titration (Table S4). In the case of many
resonances, the T2 relaxation times did not decrease linearly
with increasing paramagnetic ion concentrations. The change
between the first two points of titration (for which no
paramagnetic ion was present, followed by the addition of 0.5
mM manganese(II) ions) was the largest, while, for the
remaining titration points, diminishing reduction of T2
relaxation times was observed. For this reason, the slope of
the linear function fitted for the first two points was used to
define the attenuation of the T2 relaxation times.
We found that the resonances of D-iGln-βCH2 and the
mannose group (Figure 5, columns 2 and 6, respectively)
quickly decline (large T2 attenuation, Figure 6), which
indicates that these terminal groups are solvent-exposed.
Such localization of D-iGln on the surface is also in agreement
with the result of the STD epitope mapping. In contrast, the
signals of the adamantyl moiety, Ada-δCH, are hardly affected
by the addition of the paramagnetic ions and display similar
line widths and intensities at high or low paramagnetic ion
concentrations (Figure 5, column 2). This indicates that the
adamantyl group is immersed in the lipid bilayer, which
protects it from the relaxation effects of the water-solvated
paramagnetic ions (low T2 attenuation, Figure 6). Between the
two extremes, the attenuation is gradually changing: the
resonances of the Ala-βMe group (Figure 5, column 3) and the
linker residue (Lnk) (Figure 5, column 4) show intermediate
bleaching effects (Figure 6). Comparison of the bleaching
Figure 5. Broadening of 1H NMR resonances during the titration with paramagnetic manganese(II) ions for (a) D-Ad1Tp, (b) L-Ad1Tp, (c) Man-D-
Ad1Tp, and (d) Man-L-Ad1Tp.
Figure 6. Attenuation of the relaxation times upon the addition of
paramagnetic ions as measured by the slope of the linear function
fitted for T2 relaxation times at the first two points of the titration, that
is, at 0 and 0.5 mM of paramagnetic ion concentrations.
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effects of the amide resonances in Figure 6 shows that for all
derivatives the D-iGln-NH shows the fastest initial decrease in
T2 relaxation times (large T2 attenuation), resulting in
broadening of line width and the loss of intensity upon
increasing paramagnetic ion concentrations (Figure 5, column
1). This further confirms the solvent exposure of the PGN
fragment cargo.
The PRE data indicates that the targeting mannosyl group
and the PGN fragment cargo of the derivatives are available for
interaction with cell surface receptors. These findings are in
line with previous observations for related PGN-based
adjuvants with adamantyl-2-yl attachment,78 whereby the
mannose group was found on the surface of liposomes by
dynamic light scattering and atomic force microscopy. Specific
binding of the mannosyl group on cell surface receptors79 such
as the mannose receptor (MR) could explain improved
immune stimulatory properties of the mannosylated deriva-
tives. The MR80 is a C-type lectin receptor expressed in
macrophages, which facilitates the internalization of micro-
organisms and glycoproteins with terminal mannose residues.
Recognition by the MR could increase the uptake of the
mannosylated derivatives and hence contribute to their
immune stimulation properties.
We found that the PRE data indicated that the adamantyl
group is intercalated into the lipid bilayer and serves as an
anchor to the membrane. In comparison, amantadine was
located in the head group region of phosphocholine
membranes at the surface of the lipid bilayer, as observed by
neutron and X-ray diffraction.28 However, occasionally, it was
also shown to penetrate the deeper regions of the bilayer,
which was also confirmed by EPR.29 In a liquid-state NMR
study,30 it was possible to perform irradiation of a number of
lipid resonances, enabling the more precise mapping of
amantadine by STD. This showed that the drug is distributed
in a wide region, starting from the glycerol CH2 group near the
negatively charged phosphate group and the entire hydro-
carbon region. Thus, it appears that the adamantane group can
position itself in various regions of the membrane. The surface
location of amantadine is probably driven by electrostatic
attraction between the negatively charged phosphate head
groups of the lipids and the positive charge of the amine group
on amantadine, similarly to the case of the nonmannosylated
PGN derivatives, which also have a positively charged terminal
amine group. Deeper penetration of amantadine into the
aliphatic lipid chain region is likely driven by the strong
hydrophobicity of the adamantane group. This interaction
might also become more dominant for the mannosylated
derivatives, in which the charged amine groups at the N
termini are capped by the neutral mannose groups.
As we noted earlier, the nonmannosylated compounds are
incorporated more efficiently into the bilayer at both
temperatures, while attachment of the mannose group reduces
the incorporation efficiency. Taking into consideration the
results obtained regarding the conformation, localization, and
orientation of the derivatives in the bilayer, we propose the
following molecular interpretation for this finding. The
nonmannosylated derivatives are in zwitterionic forms,
containing an ionized N-terminal amine and a C-terminal
carboxyl group. The interaction of these compounds could
involve electrostatic contacts from their charged termini to the
positively charged choline groups and the negatively charged
phosphate groups in the lipid molecules. In contrast, the
mannosylated derivatives bear only a negatively charged C-
terminus as the N-terminus is capped by the neutral, albeit
polar mannose moiety, making only one ionic interaction
possible with the lipids. The presence of two charged groups in
the nonmannosylated compounds likely prevents deeper
incorporation into the lipid bilayer, explaining the observed
STD patterns. However, these two electrostatic interactions in
the upper layer of the assembly can reasonably be assumed to
result in a stronger interaction with the lipid molecules relative
to the mannosylated compounds, where only one strong
electrostatic interaction is present, thus leading to stronger
incorporation efficiencies of the nonmannosylated compounds.
Furthermore, we observed that the chirality of the adamantyl
group influences the incorporation efficiency, which might be
correlated with the membrane-associated conformation in the
following way. D-Ad1Tp interacts weaker with the lipid bilayer
than L-Ad1Tp, with a most pronounced difference at low
temperature (32 vs 49%) and a smaller distinction at high
temperature (51 vs 56%). At room temperature, D-Ad1Tp
adopts a bent conformation, which may be attributed to an
ionic interaction between the charged C- and N-terminal
groups. Such an intramolecular contact might prevent or at
least compete with the charged terminals engaging in
intermolecular interactions with the lipid molecules, and this
could explain the weaker encapsulation into the bilayer. For
the mannosylated derivatives, the encapsulation between the
diastereoisomers differs less at room temperature (19 vs 24%)
and is similar at 37 °C (43 vs 42%). A subpopulation of Man-L-
Ad1Tp determined at room temperature also displayed a bent
backbone enabled by an intramolecular hydrogen bond
between the termini. Similar to the reasoning above, these
groups may not be fully available for intermolecular electro-
static interactions with polar lipid groups, which might explain
lower encapsulation. These observations and explanations are
in agreement with reports showing that the lipophilicity of
drug molecules has been found to be affected by the formation
of intramolecular hydrogen bonds, which shields the hydrogen-
bond donor and acceptor groups from intermolecular
interactions.81 In the case of the PGN molecules, the
interaction with the lipids is likely driven by a combination
of electrostatic interactions, transient hydrogen bonds, and van
der Waals forces. Bent intramolecular conformations could
affect the availability of the polar groups for the first two, for
electrostatic interactions and transient hydrogen bonds, thus
leading to the modulation of the incorporation strength of the
diastereoisomers.
Binding to CLRs. The adjuvant activity of the adamanty-
lated PGN derivatives likely involves interaction with multiple
receptors of the innate immune system; however, these
receptors have not yet been unequivocally clarified. Targeting
via the mannosyl group requires recognition by cell surface
CLRs, such as the MR, that facilitate internalization of
microbes by binding of terminal mannose groups and could
therefore contribute to the increased uptake and to the
augmentation of the adjuvant effect. Targeting was evidenced16
by the more effective adjuvant activity of the derivatives with
the mannose-targeting group than that of the nonmannosy-
lated parent compounds.
The interaction of CLRs with the mannosyl-targeting group
can be mimicked by plant lectins such as concanavalin A (Con
A). The specificity of carbohydrate−lectin interactions is often
studied using Con A, with detection of the changes in
hydrodynamic radius by dynamic light scattering.82 Here, we
used NMR diffusion experiments to detect changes in
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translational diffusion upon the addition of Con A. To see
whether the mannosyl group is available for binding to
endogenous cell surface receptors, we added 1 mM Con A to
the bicelle solutions of the PGN derivatives in the presence of
calcium ions and monitored the translational diffusion of the
peptides. In both cases, a decrease in the diffusion constants
was observed (Figure 7), which was also accompanied by
chemical shift changes.
Due to fast exchange between the various glycopeptide-
containing species, only a single apparent diffusion coefficient
is observable in the DOSY spectrum, which is a population-
averaged value of the diffusion coefficients of the individual
complexes present. The observed decrease in the translational
diffusion coefficient of the PGN derivatives may be attributed
to the glycopeptide cross-linking bicelles around the lectin,
which is able to bind up to four mannosyl groups. This might
indicate that the mannosyl moiety of both derivatives
incorporated into bilayers is available for binding to cell
surface CLRs.
■ CONCLUSIONS
PGN fragments such as muramyl peptides83 activate the
immune system through induction of the NLR pathway, i.e.,
molecular recognition by intracellular NOD-like receptors.
Their activity can be enhanced by other types of PRR, such as
toll-like receptor (TLR) activation. Lipids act as TLR ligands
and can therefore synergistically enhance the immune response
to PGN compounds, which is known as PRR crosstalk.
Mannose receptors on the other hand are CLR receptors,
which can improve the uptake of the compounds and thereby
modulate the immune stimulation. Better incorporation of
compounds into the bicelles provides increased ligand density,
which positively influences the stimulation of the immune
response. The activity is thus controlled by the incorporated
PGN-based peptide and the synergistic effect of lipid
nanoparticles with an additional effect of the targeting group
in the mannosylated compounds.
Lipid incorporation efficiencies of the adamantylated PGN
derivatives were between 19 and 49% and 42 and 56% at room
temperature and 37 °C, respectively, which are much improved
compared to the lipid incorporation found for the whole
monomeric PGN fragment. The parent adamantylated
compounds showed higher lipid encapsulation than their
mannosylated conjugates. Immune co-stimulation activities of
the derivatives in vitro were amplified upon incorporation into
liposomes and more so for the nonmannosylated derivatives
than for the compounds with mannose groups, which may be
attributed to their higher increase in lipid incorporation
efficiency.
It was also found that the nonmannosylated compounds are
only in contact with the upper parts of the bilayer, while the
derivatives with mannose groups penetrate deeper in the
bilayer. In all cases, the PGN cargo fragments and the
mannosyl groups of the glycopeptide derivatives are close to
the surface of the bilayer. These observations can be
rationalized by considering possible electrostatic interactions
between the charged groups of the derivatives and those of the
lipid molecules. The membrane interaction appears to be
slightly influenced by the chirality of the adamantyl group and
correlated with the membrane-associated conformations. This
effect could be related to the availability of the charged or polar
groups for intermolecular interactions with the lipid molecules
and thereby explains differences in incorporation efficiency.
On the basis of the findings by NMR, we propose that the
mannosylated adamantylated PGN derivatives in liposome
formulations could intercalate themselves into the lipid bilayer
and would also be present in the inner aqueous compartment
due to their solubility in water. In the bilayer bound
arrangement, which is depicted in Scheme 2, the targeting
mannosyl group is able to interact with cell surface CLRs,
while the PGN fragment cargo is available for contact with the
cell surface or, after internalization, cytosolic receptors. Thus,
we show that different functional groups of the PGN
derivatives designed for liposomal delivery are located on the
surface of the lipid assembly in an arrangement that enables
interactions with the targeted receptors. The conformations of
the molecules solvated in the inner aqueous compartment
Figure 7. Comparison of DOSY plots for (a) Man-D-Ad1Tp and (b) Man-L-Ad1Tp in the presence of bicelles (black) and after the addition of 1
mM Con A (red).
Scheme 2. Proposed Interactions of the Mannosylated PGN
Derivatives Embedded in Liposomes with Cell Surface
Receptors of Antigen-Presenting Cells (APCs)a
aThe figure is for the illustration of the mutual arrangement of the
components and is not to scale.
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might be different than those of the membrane-associated
molecules.
By elucidating the molecular details of membrane inter-
actions of adamantylated PGN derivatives, we have taken the
first steps toward understanding their lipid formulations, which
will enable further modifications to improve the efficiency of
membrane encapsulation and the adjuvant activity of this type
of molecules. To deliver a cargo in a vaccination context,
multiple complementary functionalizations of liposomes are
proposed such as sufficient membrane incorporation, active
targeting of the cell surface and innate immune signaling
receptors, stealth, and controlled release. We conclude that
good compounds for functionalizing liposomes should contain
lipophilic groups, which could penetrate the lipid bilayer, and
homing groups to interact with target receptors and to
accumulate the cargo at the site of biological action. The
lipophilic adamantane group attached to the peptide backbone
in the studied PGN derivatives achieves encapsulation of the
compounds into the lipid bilayer, thus providing safe delivery
of the payload. Additionally, the attachment of mannose as a
ligand for specific receptors expressed on cell surfaces enables
active targeting. We confirmed that both the mannose group
and the PGN payload are available on the surface of the
bilayer. Having achieved sufficient membrane incorporation as
well as active targeting for both the uptake and immune
response, further improvements could include functionaliza-
tion to achieve stealth from immune surveillance, e.g., by
PEGylation. Furthermore, while the dynamic equilibrium
present between the free state in the aqueous solution and
the lipid-membrane-bound state of the adamantylated PGM
derivatives enables a prolonged release of the payload, this
could be improved by incorporating a controlled release
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